Laser vs shock wave: which zaps heel pain best?
NCT ID NCT07287046
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two non-invasive treatments for plantar fasciitis, a common cause of heel pain. 28 adults will receive either high-intensity laser therapy or focused shock wave therapy, plus exercises. Researchers will measure pain and foot function over 12 weeks to see which works better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-intensity laser therapy and focused extracorporeal shock wave therapy
- What this could lead to
- If one treatment works better, it could offer a more effective, non-invasive option for easing heel pain from plantar fasciitis.
- What could go wrong
- This is a small, early-stage trial with only 28 people, so results may not apply to everyone. Both treatments are already used, so no major breakthrough is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 28 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18-70 years * Pain was worse in the initial step after and an extended period of rest * Pain was decreased initially after the first steps but exacerbated with increased activity * VAS ≥ 4 * Pain was localized and sharp but not radiating, * Pain was reproduced with palpation of the plantar fascia Exclusion Criteria: * Have Wound/Infection/tumor in treatment area * History of foot trauma in 3 months * History of intervention at plantar fascia in 6 months such as Ultrasound therapy, steroid injection, surgery or botulinum toxin injection * Pain medication within one week before participation * Patient wasn't desired to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Plantar fasciitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heel pain Face-Off: nerve zapping vs. Blood-Based injection vs. both
- Tape or stretch? trial tests two ways to ease heel pain
- Nature trails may be a new prescription for foot pain
- Can 3D-Printed insoles beat milled ones for heel pain?
- Blood marker may shed light on stubborn heel pain
- Can a CBD cream soothe heel pain fast?